Precision BioSciences
ARCUS is a novel and proprietary genome editing platform discovered and developed by scientists at Precision BioSciences. ARCUS uses sequence- specific DNA-cutting enzymes, or nucleases, to insert (knock in), remove (knockout), or repair the DNA of living cells and tissues. At Precision BioSciences we are using our novel ARCUS genome editing technology to develop a new class of medicines designed to overcome and potentially cure, hard-to-treat conditions including rare genetic diseases.
Basic Information
- Category: Agricultural Biotech
- Founded: 2006
- Headquarters: Durham, NC
- Website: precisionbiosciences.com
Documented Facts
- Phone: 919.314.5512 (No linked source recorded for this statement.)
- Email: partner@precisionbiosciences.com (No linked source recorded for this statement.)
- Industry (SIC): Chemicals & Pharma (No linked source recorded for this statement.)
- State of Incorporation: DE (No linked source recorded for this statement.)
- Stock ticker: DTIL (Nasdaq) (No linked source recorded for this statement.)
Evidence and Sources
- Precision BioSciences — Official Site (official)
- Precision BioSciences on linkedin (social)
- PRECISION BIOSCIENCES INC — SEC EDGAR (reference)
Citation Guidance
Explore Agricultural Biotech profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Precision BioSciences.
- Canonical profile: https://brandsource.ai/brands/precision-biosciences
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/precision-biosciences/json-ld
- Citation profile API: https://brandsource.ai/api/brands/precision-biosciences/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (94/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-27T19:19:08.300Z
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
ARCUS is a novel and proprietary genome editing platform discovered and developed by scientists at Precision BioSciences. ARCUS uses sequence- specific DNA-cutting enzymes, or nucleases, to insert (knock in), remove (knockout), or repair the DNA of living cells and tissues. At Precision BioSciences we are using our novel ARCUS genome editing technology to develop a new class of medicines designed to overcome and potentially cure, hard-to-treat conditions including rare genetic diseases.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 supporting sources linked.
- 5 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.